The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment
PDF
Cite
Share
Request
General Radiology - Review
P: 186-192
September 2010

The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment

Diagn Interv Radiol 2010;16(3):186-192
1. Molecular Imaging Program, National Cancer Institute National Institutes of Health, Bethesda, Maryland, USA
2. Clinical Center Radiology and Imaging Sciences, National Institutes of Health, Bethesda, Maryland, USA
3. Philips Healthcare Cleveland, Ohio, USA
No information available.
No information available
Received Date: 24.12.2008
Accepted Date: 03.03.2009
PDF
Cite
Share
Request

ABSTRACT

Angiogenesis is a key step in the pathophysiology of tumor growth and metastatic spread. Recently, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has emerged as a method for assessing angiogenesis both during the initial diagnosis and for follow up of anti-angiogenic therapies. In this review, we discuss the technical aspects of implementing DCE-MRI in clinical practice with emphasis on acquisition methods and analytic techniques.